Acasti Pharma Inc. buy melinda
Start price
12.09.21
/
50%
€11.77
Target price
12.09.22
€15.00
Performance (%)
-60.64%
End price
13.09.22
€4.63
Summary
This prediction ended on 13.09.22 with a price of €4.63. Massive losses of -60.64% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Acasti Pharma Inc. | -10.204% | -10.204% | 13.081% |
iShares Core DAX® | 1.804% | -0.748% | 13.168% |
iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to melinda what are the pros and cons of Acasti Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Acasti Pharma Inc diskutieren
Buy mit Kursziel 2,5
In the thread Trading Acasti Pharma Inc
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Acasti Pharma Inc.
Acasti Pharma Inc.
Start price
Target price
Perf. (%)
€9.79
29.11.20
29.11.20
€24.00
22.55%
04.12.20
04.12.20
Could be worthwhile Investment >10% per year
Acasti Pharma Inc.
Start price
Target price
Perf. (%)
€38.96
01.06.19
01.06.19
€49.79
25.06.19
25.06.19
28.90%
25.06.19
25.06.19
Could be worthwhile Investment >10% per year
Acasti Pharma Inc.
Start price
Target price
Perf. (%)
€32.90
22.05.18
22.05.18
€48.49
27.09.18
27.09.18
32.91%
27.09.18
27.09.18
Could be worthwhile Investment >10% per year